Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Cefprozil Granule vs Suspension in Healthy Volunteers
NCT04414254Phase 1Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Sep 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cefprozil in bacterial infection (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Maximum Plasma Concentration at 71 Days, Area Under the Curve from time 0 to last measurable concentration at 71 Days and 1 more. Started Sep 2018; status: completed.
02
Drugs
cefprozil
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04414254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414254.